Pzena Investment Management »

Halozyme Therapeutics shares owned by Pzena Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Pzena Investment Management from 13F filings

Historical chart of Pzena Investment Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Pzena Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Pzena Investment Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $352k 9.2k 38.19
2022-12-31 $825k 15k 56.90
2022-03-31 $628k 16k 39.90